Hemofarm

Highly Engaged Employees

Hemofarm is the leading pharmaceutical company in Serbia and the region, prioritizing health with a significant market presence. Founded in 1960, it commands a 17.3% share of the Serbian pharmaceutical market by financial value. Hemofarm also leads in exporting Serbian medicinal products, holding a 79.1% export share, making it the country's foremost exporter. Its production capacity is substantial, manufacturing over 4 billion tablets and capsules annually across its 3 locations. Operating within the Pharmaceuticals and Healthcare industries, Hemofarm provides a wide array of products, including generic pharmaceuticals, medicinal supplies, and infusion solutions. The company employs between 1,000 - 5,000 individuals, reflecting its considerable operational scale. Its commitment to quality and health is a core tenet, driving its extensive product development and manufacturing processes. Hemofarm's strategic focus on innovation and accessibility ensures it remains a vital contributor to healthcare infrastructure. As a leading player, Hemofarm actively engages in the B2B market, with a strong presence in Europe and other international territories, as indicated by hashtags like #eu and #europe. The company's long-standing history, dating back to 1960, reflects its stability and enduring impact on the pharmaceutical landscape. For insights into the dedicated professionals driving its success, one can Meet Hemofarm's team. Its consistent performance and market leadership solidify its reputation as a cornerstone of regional healthcare.